Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
71.39
-0.23 (-0.32%)
At close: Mar 3, 2025, 4:00 PM
71.80
+0.41 (0.57%)
Pre-market: Mar 4, 2025, 5:46 AM EST
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 21 analysts with 12-month price forecasts for Edwards Lifesciences stock have an average target of 79.95, with a low estimate of 60 and a high estimate of 105. The average target predicts an increase of 11.99% from the current stock price of 71.39.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Edwards Lifesciences stock from 21 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 6 | 6 |
| Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Hold | 13 | 13 | 13 | 12 | 10 | 10 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 21 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $88 → $90 | Buy | Maintains | $88 → $90 | +26.07% | Feb 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $68 → $71 | Hold | Maintains | $68 → $71 | -0.55% | Feb 13, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $85 | Buy | Reiterates | $85 | +19.06% | Feb 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $70 → $73 | Hold | Maintains | $70 → $73 | +2.26% | Feb 12, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $75 → $73 | Hold | Maintains | $75 → $73 | +2.26% | Feb 12, 2025 |
Financial Forecast
Revenue This Year
6.00B
from 5.44B
Increased by 10.27%
Revenue Next Year
6.58B
from 6.00B
Increased by 9.72%
EPS This Year
2.53
from 6.97
Decreased by -63.76%
EPS Next Year
2.83
from 2.53
Increased by 12.03%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.2B | 6.9B | 7.7B | ||
| Avg | 6.0B | 6.6B | 7.3B | ||
| Low | 5.6B | 6.1B | 6.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.5% | 14.6% | 16.8% | ||
| Avg | 10.3% | 9.7% | 10.2% | ||
| Low | 3.7% | 1.3% | -1.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.63 | 3.08 | 3.45 | ||
| Avg | 2.53 | 2.83 | 3.18 | ||
| Low | 2.35 | 2.52 | 2.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -62.3% | 21.8% | 22.0% | ||
| Avg | -63.8% | 12.0% | 12.3% | ||
| Low | -66.2% | -0.3% | -4.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.